AI assistant
Sending…
IGC Pharma, Inc. — Director's Dealing 2021
May 17, 2021
34705_dirs_2021-05-17_cddbf6f1-2d54-4535-8678-ff9ab8ecabdd.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: India Globalization Capital, Inc. (IGC)
CIK: 0001326205
Period of Report: 2021-03-31
Reporting Person: GRIMALDI CLAUDIA (Vice President & PFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-11-03 | Common Stock | G | 100000 | — | Disposed | 1037987 | Direct |
| 2021-05-13 | Common Stock | G | 500000 | — | Disposed | 537987 | Direct |
| 2021-05-13 | Common Stock | A | 250000 | — | Acquired | 787987 | Direct |
Footnotes
F1: Represents restricted shares of common stock subject to vesting over three years.
More from IGC Pharma, Inc.
Capital/Financing Update
2026
Jun 8
Interim / Quarterly Report
2026
May 15
Capital/Financing Update
2026
Apr 20
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 18
Director's Dealing
2026
Feb 4
Director's Dealing
2026
Jan 20
Capital/Financing Update
2026
Jan 6
Regulatory Filings
2026
Jan 2
Capital/Financing Update
2025
Dec 15